Background We aimed to develop a sensitive assay to quantitate serum concentrations of both androstenedione and testosterone within the female range simultaneously, using liquid chromatography-tandem mass spectrometry (LC-MS/ MS) for use in the routine clinical laboratory and to compare this method with immunoassay.
Introduction
Testosterone concentration is routinely requested in the investigation of oligo-or amenorrhoea, hirsutism and/or acne in women. The calculation of a free androgen index (FAI) using testosterone and sex-hormone-binding globulin (SHBG) concentrations has been shown to be a sensitive diagnostic marker of polycystic ovarian syndrome (PCOS). 1 The likelihood of a diagnosis of PCOS is increased if the androstenedione level is also raised. 2 Testosterone concentrations often do not correlate well with symptoms, but may help in prompting further investigation. A testosterone concentration of o5 nmol/ L measured by immunoassay is rarely associated with serious pathology, but higher concentrations warrant further investigation for the detection of an androgensecreting neoplasm 3 or congenital adrenal hyperplasia. 4 It has been documented that radioimmunoassays (RIAs) for androstenedione measurement may over-estimate steroid concentrations in children and adults. 5, 6 Commercial direct immunoassays for testosterone, which have almost completely replaced old extraction assays, can also lead to spuriously high measurements in women and children. 5,7--9 We report a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method which is sensitive, accurate and precise to measure androstenedione and testosterone simultaneously. This method should prove useful in the assessment of female patients presenting with hirsutism, virilization or acne. Although LC-MS/ MS assays for testosterone do exist, 10, 11 to our knowledge, none that can measure androstenedione alone or simultaneously has been reported.
Materials and methods
Androstenedione and testosterone were supplied by Sigma Diagnostics (Poole, Dorset, UK). Deuterated androstenedione (d 7 A,98% isotopic purity) and deuterated testosterone (d 2 T, 99% isotopic purity) were supplied by CDN Isotopes (Quebec, Canada).
Stock androstenedione and testosterone solutions were prepared for standardization by dissolving pure compound in methanol and stored at À201C. A separate stock solution was prepared for quality controls (QCs) for both analytes in agreement with published guidelines. 12 Mixed working standards were prepared by diluting the stock solutions of androstenedione and testosterone in phosphate-bu¡ered saline (PBS), pH 7.4, containing 0.1% bovine serum albumin (BSA), to give a range of concentrations (0--50 nmol/L) for both androstenedione and testosterone. QCs were prepared in the same manner to give concentrations of 0.3--35 nmol/L for both analytes. The use of PBS-based QCs allowed us to calculate the percentage deviation from target concentrations, which would not have been possible had we used commercial QCs. Aliquots of 500 mL were stored in microcentrifuge tubes at À201C for up to six months.
Internal standards were prepared by diluting d 7 A and d 2 T to concentrations of 0.01 and 0.02 mg/L, respectively, in methanol (high-performance liquid chromatography [HPLC] grade, Fisher, Loughborough, UK) and stored at À201C.
Sample preparation
Serum samples, standards or QC samples (200 mL) were transferred in singleton into polypropylene microcentrifuge tubes (1.5 mL). Internal standard (10 mL) and 1mL methyl-tert-butyl-ether (HPLC grade, Fisher, Loughborough, UK) were added. Following this, the tubes were stoppered and vortex mixed on a mechanical mixer for 4 min. The supernatant from each tube was then transferred into a glass tube, and the tubes were placed in a 401C heating block. The solvent was evaporated under a gentle air£ow for approximately 15 min.
The residue was then reconstituted with 100 mL of 50:50 mobile phase (water [A] and methanol [B: HPLC grade, Fisher, Loughborough, UK]), each containing 2 mmol/L ammonium acetate (Sigma, Poole, UK) and 0.1% (v/v) formic acid (Analar, VWR International, Poole, UK). The tubes were vortex mixed for 1min and extract was then transferred into a 96-well microtitre plate. The plate was sealed and transferred directly to the autosampler for analysis.
Liquid chromatography-tandem mass spectrometry
Chromatography was performed using a Shimadzu HPLC system comprising a SIL-HT sampler and a degasser with two 10-AD pumps (Shimadzu, Milton Keynes, UK). Extract (50 mL) was directly injected from the microtitre plate onto a Security Guard C18 4 mm Â 2 mm column, connected to a Synergi 4 mm Hydro-RP column (50 mm Â 3 mm), both from Phenomenex (Maccles¢eld, UK). The column was maintained at ambient temperature. Following elution from the column, the sample was pumped directly to the electrospray probe of the mass spectrometer, with no splitting or solvent diversion.
The mobile phase initially consisted of 70% B for 2 min, allowing isocratic elution. The column was then washed with 95% B for 0.5 min, then re-equilibrated with starting conditions for 1min. The £ow rate was maintained at 0.6 mL/min. The total run time was 4.3 min injection to injection.
A Quattro Micro tandem mass spectrometer (Waters, Manchester, UK) ¢tted with a Z spray ion source was used for all analyses. The instrument was operated in electrospray positive ionization mode and was directly coupled to the HPLC system. System control and data acquisition were performed with MassLynx NT 4.0 software with automated data processing, using the MassLynx QuanLynx Program provided with the mass spectrometer. Calibration curves were constructed using least-squares regression with 1/x weighting.
To tune the mass spectrometer, solutions of androstenedione and d 7 A (1mg/L in methanol) and testosterone and d 2 T (1mg/L in methanol) were infused into the ion source. The cone voltage was optimized to maximize the intensity of the precursor ions for androstenedione, d 7 A, testosterone and d 2 T, seen at m/z 287.3, m/z 294.4, m/z 289.3 and m/z 291.3, respectively. The collision energy was then adjusted to optimize the signal for the most abundant product ions, seen at m/z 96.8, m/z 99.8, m/z 109.0 and m/z 98.9, respectively. Tuning conditions for androstenedione and d 7 A were as follows: electrospray capillary voltage 0.9 kV, sample cone voltage 26 V, and collision energies 22 and 26 eV, respectively, at a collision gas pressure 3.62 Â10 À3 mBar argon. For testosterone and d 2 T, tuning conditions were as follows: electrospray capillary voltage 0.9 kV, sample cone voltage 28 V and collision energy 28 eV, at a collision gas pressure 3.62 Â10 À3 mBar argon. Desolvation gas £ow and temperature were maintained at 600 L/h and 3701C, respectively; source temperature was 1401C. Transitions were monitored in multiple reaction monitoring (MRM) mode with a dwell time of 0.2 s.
Validation
The assay was validated against published acceptance criteria for linearity, precision, recovery and sample stability. 12 
Linearity
To evaluate linearity of the calibration curves, three curves were prepared and analysed in a single batch.
The ratios of analyte peak height to internal standard peak height were plotted against androgen concentration in nmol/L. Calibration curves were judged linear if the correlation coe⁄cient (r 2 ) was better than 0.99 as calculated by weighted linear regression.
Six serum samples were subject to serial dilution with PBS containing 0.1% BSA to assess assay linearity.
Imprecision
Imprecision of the method was assessed against a range of concentrations using QC samples. These samples were analysed daily for 15 days to calculate interassay imprecision. To determine intra-assay imprecision, the same samples were analysed 12 times within one batch. Percentage deviation was calculated from the di¡erence between mean observed and nominal concentrations to assess bias.
Limit of quantitation
The lower limit of quantitation (LLOQ) was de¢ned as the concentration for which 10 replicates of PBS-based samples, prepared with low concentrations of androstenedione and testosterone, gave a coe⁄cient of variation (CV) of less than 20% and bias of less than 20%.
Recovery
The recovery was determined by comparing the concentration of each androgen in patient samples, before and after the addition of a known amount of the androgen.
We took six serum samples with androstenedione and testosterone concentrations ranging from 0.8 to 4.5 nmol/L and from 0.6 to 18 nmol/L, respectively. The concentrations of androstenedione and testosterone added to each sample were 0, 7.5, 15 and 30 nmol/L, and 0, 10, 20 and 40 nmol/L, respectively.
Sample stability
We assessed stability by carrying out:
(1) analysis of extract before and after 24 h storage at 41C, (2) analysis of a single extract injected every 8 min over 15 h, (3) analysis of serum samples after one to ¢ve freeze-thaw cycles.
Samples were judged to be stable if the change in response was less than 10%.
Ion suppression
Ion suppression is a matrix e¡ect, which occurs when compounds in a sample compete with the analyte for ionization in the source. To investigate this, we infused the following solutions directly into the mass spectrometer to give a constant background signal: 34 nmol/L deuterated testosterone in methanol and 34 nmol/L of deuterated androstenedione in methanol. An extracted serum sample was injected simultaneously via the autosampler. A reduction in the background signal is observed when ion suppression is occurring. The ion suppression is deemed signi¢cant if a reduction in signal of 410% is observed where the compound of interest elutes. 13 
Specificity
Solutions of various related steroids, both natural and synthetic, were prepared in 50% methanol/water to a ¢nal concentration of 1000 nmol/L and injected directly, without extraction. This excess concentration was chosen to allow easy identi¢cation of any potentially interfering peaks. Any compounds found to give a signal in the speci¢c channels for testosterone, androstenedione or their deuterated counterparts were subsequently prepared to the same concentration in PBS containing 0.1% BSA and extracted along with a full standard curve and QCs to allow quantitation. Steroids tested were levonorgestrel, 19 nortestosterone, estrone, dehydroepiandrosterone, oestradiol, epitestosterone, cyproterone acetate, desogestrel, ethinyloestradiol and norethisterone.
Accuracy
To assess the accuracy of our method, we compared our assay with an established LC-MS/MS method 10 (n ¼ 28) and three pools provided by the United Kingdom National QualityAssessment Scheme (UKNEQAS) with GC-MS assigned values (n ¼ 4) for testosterone.
Comparative assays
We compared the results obtained by LC-MS/MS with those of a non-extracted RIA method for androstenedione (DSL-3800 Active, Diagnostic Systems Laboratories Inc., TX, USA) and those of the Roche E170 electrochemiluminescence immunoassay (ECLIA) for testosterone (Roche Diagnostics, Lewes, UK). Samples from patients were stored at À301C until analysis, ¢rst by these methods and then by LC-MS/MS. The samples taken for analysis for androstenedione and testosterone were subject to local ethical approval.
Androstenedione concentrations were measured in 46 female and 46 male anonymized sera by RIA and LC-MS/MS. Testosterone concentrations were measured in 77 female and 52 male anonymized sera by both ECLIA and LC-MS/MS.We then assessed the accuracy of the ECLIA method by analysing low concentra-tion (0.3 and 1.0 nmol/L) QC samples 10 times. These QCs were made up in PBS containing 0.1% BSA to reduce any matrix e¡ects and possible crossreactivities. Although the LC-MS/MS method is aimed at the routine measurement of female samples, male samples were included in the comparison to allow us to assess the linear range of the assay. Including male samples in the comparison would also allow us to use this method for any male samples that gave anomalous testosterone results by immunoassay.
Statistical analysis
All statistical analyses were performed using Analyseit software (Analyse-it Software Ltd, Leeds, UK).
Results

Validation
Using the chromatographic conditions above, androstenedione and testosterone co-eluted with their deuterated counterparts. Androstenedione and d 7 A, and testosterone and d 2 T were found to have retention times of 1.8 and 2.3 min, respectively. There were no interfering peaks (Figure 1) . Figure 2 shows the result of investigation for ion suppression. The peak for androstenedione is shown in Figure 2b, eluting at 1.8 min. Figure 2a represents the constant infusion of deuterated androstenedione, showing that the main ion suppression occurs at 0.6 and 3.0 min. The peak for testosterone ( Figure 2d ) is shown to elute at 2.3 min. The main ion suppression occurs at 0.5--1.0 min and 3.0 min (Figure 2c ). Both androgens are seen to elute away from the main areas of ion suppression.
The standard curve was linear to 50 nmol/L for both androgens, with a correlation coe⁄cient (r 2 ) of 0.999 (n ¼ 3) (Figure 3 ). Serial dilution of six serum samples demonstrated dilutional linearity ( Table 1) .
The lower limit of quanti¢cation was 0.25 nmol/L for both androgens. At this concentration, the %CVand bias of 10 replicates were 10.9% and À11.5%, respectively, for androstenedione and 11.9% and 7.5%, respectively, for testosterone. Concentrations below 0.25 nmol/L result in %CVs greater than the acceptable limit of 20%.
Both inter-and intra-assay imprecision were below 10% CV for androstenedione and testosterone at all concentrations, with less than 15% bias for all samples ( Table 2 ). The mean recovery of androstenedione was 99% (range 93--104%) and for testosterone 93% (range 89--95%). In all experiments for stability, there was a decrease in response of less than 5.5% in measured concentrations for both androgens. There was no loss of sensitivity over repeat injection for 15 h; the extract was stable for 24 h at 41C and samples were stable for ¢ve freeze--thaw cycles.
None of the steroids tested for speci¢city gave a sig-ni¢cant signal in the speci¢c MRM channels for androstenedione, testosterone or the internal standards. Bland--Altman analysis of female samples analysed for testosterone by this method and an established LC-MS/MS method in routine use in the SAS Centre for Steroid Hormones (Leeds), showed good agreement (Figure 4) . Our method demonstrated a small negative bias of 0.05 nmol/L. Analysis of UKNEQAS samples also demonstrated good agreement for all four replicates for each of the three pools (Table 3) . On examining results from female samples alone (n ¼ 77), we found the correlation (r 2 ) was 0.25. The regression equation was LC-MS/MS (nmol/ L) ¼ 0.74 Â ECLIA (nmol/L) þ 0.10. Bland--Altman analysis revealed a bias of À0.24 nmol/L, i.e., concentrations obtained by ECLIA were higher than those obtained by LC-MS/MS (Figure 5c ). One signi¢cant outlier was observed in which the ECLIA testosterone concentration was almost 6 nmol/L higher than the LC-MS/MS.
Comparison with other methods
Repeat analysis of PBS-based samples using the LC-MS/MS and automated immunoassay for testosterone showed that the ECLIA underestimated testosterone considerably in the female range (Table 4 ).
Discussion
The chromatograms that are produced with this method are clear with no interfering peaks seen near the relevant retention times. Despite the use of liquid-liquid extraction, which theoretically should remove many substances that may result in ion suppression, regions of ion suppression are observed. The chromatography has been optimized to ensure that both testosterone and androstenedione elute away from these areas, and therefore negligible ion suppression is seen.
The assay's LLOQ and good linearity at high concentrations would make the method, particularly for testosterone, applicable to both female and male samples. The high working range will also cover both the normal and pathological concentrations; therefore the need for sample dilution is extremely rare.
Stability studies showed that both androstenedione and testosterone are stable for 24 h when extracted and stored in the fridge. There was no systematic loss in sensitivity upon repeat injection over 15 h, demonstrating that long assays may be performed without a decline in performance. It was also observed that both testosterone and androstenedione were stable for at least ¢ve freeze--thaw cycles.
None of the steroids tested showed signi¢cant interference even at high concentrations. However, the authors acknowledge that only a limited number of steroids were tested. Metabolites of steroids or drugs may possibly cause interfering peaks, but as these are not commercially available, it would be impractical to test these and the vast number of other steroids that are available.
By comparing our method with both LC-MS/MS and GC-MS (UKNEQAS samples), we are con¢dent that our assay gives accurate results for testosterone. Unfortunately, it was not possible to conduct such experiments for androstenedione as GC-MS target pools and routine LC-MS/MS assays are not, to our knowledge, available for this analyte.
Although we appreciate that comparing an extracted LC-MS/MS assay to non-extracted immunoassays is not comparing like with like, our intention was to compare the results obtained by our new assay (intended for routine use) with the methods that were in routine use in our laboratory at the time. These comparisons showed that much lower results were obtained by the LC-MS/MS method for androstenedione. This is perhaps due to the speci¢city of the LC-MS/MS assay because the calibrators from the RIA kit agreed closely with those of the LC-MS/MS assay. Testosterone results by both methods compared well with a high correlation coe⁄cient and low bias (0.22 nmol/L); however, female samples alone showed a much poorer correlation and a slightly larger bias. As we are con¢dent of the LC-MS/MS method's accuracy and precision at these low concentrations, we can conclude that the automated immunoassay's performance is questionable in this range. The ¢nding of a high bias by the immunoassay from the nominal testosterone concentration in an arti¢cial matrix supports this. This method has been used routinely for female samples in our laboratory for 13 months, measuring in excess of 1200 samples in this time. The method is also often used to measure testosterone in male serum, including samples from other hospitals in the region, when the results of immunoassay are under question.
Summary
We have developed a simple, sensitive, robust, accurate and precise LC-MS/MS method for simultaneous determination of androstenedione and testosterone. Using a preparatory liquid--liquid extraction step, combined with adequate chromatography, this method separates androstenedione and testosterone from possible interfering substances, thereby removing inherent problems seen with direct immunoassay. This method will prove useful in clinical practice. 
